MindMed to Present at Leerink’s Global Healthcare Conference 2025
NEW YORK–(BUSINESS WIRE)–
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will present at Leerink’s Global Healthcare Conference:
- Leerink’s Global Healthcare Conference
- Format: Fireside Chat and 1×1 Meetings
- Date: March 11, 2025 at 3:40 PM ET
- Location: Miami Beach, FL
- Webcast Link: Leerink’s Global Healthcare Conference 2025
Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following each event.
About MindMed
MindMed is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. MindMed trades on Nasdaq under the symbol MNMD.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250304577180/en/
For Media:[email protected]
For Investors:[email protected]
KEYWORDS: United States North America Canada Florida New York
INDUSTRY KEYWORDS: Science Other Science Biotechnology Research Pharmaceutical General Health Health Mental Health
MEDIA:
| Logo |
 |